Does the role The MS Society plays in progressive MS a useful one?
There is little doubt that MS is a bad disease:
- MS reduces lifespan by ~10 years on average
- 50% of MSers are unemployed 8 to 10 years after diagnosis
- Divorce or separation rates are double the population average
- Society views the quality of life of an MSer with an EDSS of 8 or 9 as being worse than death
- Suicide rates in MSers are 4x the national average
- The cost to society of someone with an EDSS of 6 or greater is over £50,000 per year
- Given time the majority of MSers will become disabled
................. and the list could go on.
This diatribe of bad news is based on data and a world view that has emerged prior to the introduction of DMTs, in particular the newer generation DMTs with greater efficacy.
I am positive that once aggressive early treatment becomes the norm, we will delay, slow-down the course of, and possibly prevent progressive MS. Great, but were does that leave people with progressive MS at present?
At "MS Life" I will highlight the research activity that is occurring in progressive MS. For example a search on www.clinicaltrials.gov using the search term "progressive multiple sclerosis" resulted in 106 hits.
http://clinicaltrials.gov/ct2/results?term=progressive+multiple+sclerosis
Is this not an indication that something is bound to emerge, in the near future, to treat progressive MS?
In support of The MS Society and MS Life: a large number of the initiatives into finding an effective treatment for progressive MS have been led by funding from the MS Societies. A few examples are, the Lamotrigine SPMS trial, the MRI add-on component to the CUPID study, the PROMISE 2010 programme, the UK clinical trial network, which has the specific task of designing and starting a neuroprotective trial in progressive MS. There are other projects on the table waiting funding decisions to tackle the problem of doing trials in progressive MS. Finally, there are a several industry-sponsored trials that are either fully recruited, currently recruiting, or are about to start recruiting participants for progressive MS studies.
Is this not good news?
If I had progressive MS I would look at all of this activity as being positive; we need optimism not cynicism.
If you are free on the 14th and 15th of April I suggest you attend the MS Life meeting to hear about it for your-self.
For those would need financial help getting there the MS Society is offering travel grants.
Finally, I would appreciate it if you could respond to the new surveys on the right? I would like to use the results to illustrate a point in my talk.
Thank you.